24 results
Elbow Injuries - Elbow Dislocations - Anterior vs Posterior #Diagnosis #EM #Ortho #Elbow #Dislocation #Anterior #Posterior
- Anterior vs Posterior ... #Diagnosis #EM ... #Ortho #Elbow #Dislocation ... #Anterior #Posterior
Knee Dislocation Classification: Anterior vs Posterior  #Diagnosis #EM #Ortho #Sports #Knee #Dislocation #Diagram #Classification #Anterior
Classification: Anterior vs Posterior ... #Diagnosis #EM ... #Ortho #Sports ... Classification #Anterior #Posterior
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Care TRICC - NEJM ... 1999 - ICU FOCUS ... - NEJM 2011 - Hip ... UGIB TRISS - NEJM ... /vmoitra) #EBM
Hip Dislocation - Posterior dislocation (90%): Typically presents with hip flexed and adducted; 5-15% of posterior
Dislocation - Posterior ... adducted; 5-15% of posterior ... rotated #Dagnosis #EM ... #Ortho #Hip #Dislocation ... Classification #Anterior #Posterior
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Supracondylar Fracture Classification - Type I: Non-displaced. Type II: Displaced with intact anterior cortex. Type III:
both anterior and posterior ... cortex) #Diagnosis #EM ... #Ortho #Supracondylar
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
The arrows point to a subendocardial region with poor contrast enhancement due to ischemia. This is
This is posterior ... #Clinical #EM #IM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM